These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 22886301)

  • 1. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation.
    Liu Y; Berendsen AD; Jia S; Lotinun S; Baron R; Ferrara N; Olsen BR
    J Clin Invest; 2012 Sep; 122(9):3101-13. PubMed ID: 22886301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of adipogenesis and osteogenesis in mesenchymal stem cells by vascular endothelial growth factor A.
    Berendsen AD; Olsen BR
    J Intern Med; 2015 Jun; 277(6):674-80. PubMed ID: 25779338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How vascular endothelial growth factor-A (VEGF) regulates differentiation of mesenchymal stem cells.
    Berendsen AD; Olsen BR
    J Histochem Cytochem; 2014 Feb; 62(2):103-8. PubMed ID: 24309509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel PPARγ2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation.
    Kim J; Ko J
    Cell Death Differ; 2014 Oct; 21(10):1642-55. PubMed ID: 24948012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling.
    Chung JE; Park JH; Yun JW; Kang YH; Park BW; Hwang SC; Cho YC; Sung IY; Woo DK; Byun JH
    Int J Med Sci; 2016; 13(11):806-818. PubMed ID: 27877072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling.
    Sun H; Kim JK; Mortensen R; Mutyaba LP; Hankenson KD; Krebsbach PH
    Stem Cells; 2013 Oct; 31(10):2183-92. PubMed ID: 23766271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
    J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct VEGF functions during bone development and homeostasis.
    Liu Y; Olsen BR
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):363-8. PubMed ID: 24699630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoidin Receptor 2 Controls Bone Formation and Marrow Adipogenesis.
    Ge C; Wang Z; Zhao G; Li B; Liao J; Sun H; Franceschi RT
    J Bone Miner Res; 2016 Dec; 31(12):2193-2203. PubMed ID: 27341689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
    Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
    J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.
    Shen GS; Zhou HB; Zhang H; Chen B; Liu ZP; Yuan Y; Zhou XZ; Xu YJ
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3644-3654. PubMed ID: 30279140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor NKX1-2 promotes adipogenesis and may contribute to a balance between adipocyte and osteoblast differentiation.
    Chen N; Schill RL; O'Donnell M; Xu K; Bagchi DP; MacDougald OA; Koenig RJ; Xu B
    J Biol Chem; 2019 Nov; 294(48):18408-18420. PubMed ID: 31615896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Bone Turnover in Chronic Kidney Disease Is Associated with Decreased VEGF-A Expression and Osteoblast Differentiation.
    Chen NX; O'Neill KD; Allen MR; Newman CL; Moe SM
    Am J Nephrol; 2015; 41(6):464-73. PubMed ID: 26228644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).
    Stechschulte LA; Ge C; Hinds TD; Sanchez ER; Franceschi RT; Lecka-Czernik B
    J Biol Chem; 2016 Nov; 291(47):24475-24486. PubMed ID: 27687725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jabuticaba peel extract modulates adipocyte and osteoblast differentiation of MSCs from healthy and osteoporotic rats.
    Souza ATP; Freitas GP; Lopes HB; Totoli GGC; Tarone AG; Marostica-Junior MR; Rosa AL; Beloti MM
    J Bone Miner Metab; 2021 Mar; 39(2):163-173. PubMed ID: 32889573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Botolin S; McCabe LR
    J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ox-PAPCs in the differentiation of mesenchymal stem cells (MSCs) and Runx2 and PPARγ2 expression in MSCs-like of osteoporotic patients.
    Valenti MT; Garbin U; Pasini A; Zanatta M; Stranieri C; Manfro S; Zucal C; Dalle Carbonare L
    PLoS One; 2011; 6(6):e20363. PubMed ID: 21674037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
    Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
    J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch.
    Addison WN; Fu MM; Yang HX; Lin Z; Nagano K; Gori F; Baron R
    Mol Cell Biol; 2014 Aug; 34(16):3076-85. PubMed ID: 24891617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLE3, transducing-like enhancer of split 3, suppresses osteoblast differentiation of bone marrow stromal cells.
    Kokabu S; Nguyen T; Ohte S; Sato T; Katagiri T; Yoda T; Rosen V
    Biochem Biophys Res Commun; 2013 Aug; 438(1):205-10. PubMed ID: 23880346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.